Loading…
Regencell Bioscience Holdings Limited is projected to rise to $27.44 by 2027, a +16% move from its current price of $23.71. RGC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $22.52 | $23.71 | $24.97 | +0.01% |
| May 30 | $22.04 | $23.72 | $25.51 | +0.03% |
| May 31 | $21.69 | $23.72 | $25.94 | +0.04% |
| Jun 1 | $21.39 | $23.72 | $26.31 | +0.05% |
| Jun 2 | $21.14 | $23.72 | $26.63 | +0.06% |
| Jun 3 | $20.91 | $23.73 | $26.93 | +0.08% |
| Jun 4 | $20.70 | $23.73 | $27.21 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.70 | $23.73 | $27.21 | +0.09% |
| Week 2 | $19.57 | $23.75 | $28.82 | +0.18% |
| Week 3 | $18.76 | $23.77 | $30.13 | +0.26% |
| Week 4 | $18.10 | $23.79 | $31.28 | +0.35% |
| Week 5 | $17.54 | $23.81 | $32.33 | +0.44% |
| Week 6 | $17.05 | $23.84 | $33.32 | +0.53% |
| Week 7 | $16.61 | $23.86 | $34.26 | +0.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience Holdings Limited is the asset with a current price of $23.71 and a market cap of $11.72B. It is ranked 828 in market capitalization among peers. The stock trades within a defined 30-day range and carries a near-term neutral to bullish multi-year outlook based on the provided forecast.
For 2026, the forecast shows a min of $20.54, an avg of $23.71, and a max of $33.66 with a 0% ROI and a NEUTRAL sentiment, suggesting little change on average this year. Longer-term projections imply a stronger upside, with 2027 through 2050 posting progressively higher averages and bullish sentiment, culminating in sizable ROIs by 2030 and beyond (e.g., 2030 avg $50.70; 2040 avg $122.02; 2050 avg $304.15).
A major floor 21.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 32.7% above — a clean break opens room to run.
A major ceiling 43.6% above — clearing it would confirm fresh momentum.
Key RGC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RGC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $25.64 | Sell | $25.22 | Sell |
| MA 10 | $26.58 | Sell | $26.17 | Sell |
| MA 20 | $27.49 | Sell | $27.01 | Sell |
| MA 50 | $27.75 | Sell | $27.38 | Sell |
| MA 100 | $28.36 | Sell | $26.19 | Sell |
| MA 200 | $21.89 | Buy | $22.57 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.27 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -208.13 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.45 | Sell |
| ROC (12) | -19.02 | Sell |
| Bollinger %B (20,2) | -0.06 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.18 | Sell |
| Awesome (5,34) | -2.53 | Sell |
| Ultimate (7,14,28) | 20.47 | Buy |
| Momentum (10) | -2.64 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 24.32 | Sell |
| ADX (14) | 9.48 | Neutral |
| ATR (14) | 1.07 | Info |
The 30-day technical picture is bullish in sentiment. RSI14 is 40, with a 50-day simple moving average of $27.75 and a 200-day simple moving average of $21.89.
Support is at $23.71 and resistance at $31.47, framing a 30-day range from $16.86 to $33.34. The current price sits at the support level, and the asset exhibits substantial volatility, reflected by an annualized volatility of 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $20.54 | $23.71 | $33.66 | 0% | Neutral | |
| $19.88 | $27.44 | $40.96 | +16% | Neutral | |
| $21.39 | $31.26 | $49.54 | +32% | Bullish | |
| $20.86 | $32.02 | $53.14 | +35% | Bullish | |
| $31.58 | $50.70 | $87.44 | +114% | Bullish | |
| $37.84 | $63.34 | $112.95 | +167% | Bullish | |
| $34.25 | $59.68 | $109.62 | +152% | Bullish | |
| $37.09 | $67.16 | $126.68 | +183% | Bullish | |
| $36.84 | $69.25 | $133.82 | +192% | Bullish | |
| $36.02 | $70.22 | $138.76 | +196% | Bullish | |
| $54.91 | $122.02 | $264.36 | +415% | Bullish | |
| $136.87 | $304.15 | $699.54 | +11.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $20.54 | $23.71 | $27.97 | +0.00% |
| June 2026 | $19.58 | $23.45 | $29.08 | -1.10% |
| July 2026 | $19.70 | $23.98 | $30.48 | +2.28% |
| August 2026 | $18.65 | $23.00 | $29.78 | -4.09% |
| September 2026 | $17.94 | $22.36 | $29.39 | -2.80% |
| October 2026 | $18.95 | $23.86 | $31.79 | +6.70% |
| November 2026 | $19.69 | $25.00 | $33.72 | +4.81% |
| December 2026 | $19.28 | $24.69 | $33.66 | -1.25% |
Click any year to see its month-by-month RGC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The RGC price prediction for 2026 points to an average of $23.71 (low $20.54, high $33.66) — a potential gain of 0% on today's $23.71. A consolidation phase looks the most probable path here.
In 2027, RGC is projected to trade between $19.88 and $40.96, averaging $27.44 — a potential gain of +16% from today's $23.71. That is up +16% on the projected 2026 average. Price action looks broadly range-bound.
Regencell Bioscience Holdings Limited's 2028 outlook centres on $31.26, within a $21.39 to $49.54 range. That is up +14% on the projected 2027 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, RGC could reach as high as $53.14, with a base case around $32.02 and support toward $20.86 — roughly +35% from $23.71. Momentum favours further upside here.
Expect RGC to range from $31.58 to $87.44 through 2030. The $50.70 average target implies a +114% move from current prices. That is up +58% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The RGC price prediction for 2031 points to an average of $63.34 (low $37.84, high $112.95) — a potential gain of +167% on today's $23.71. Momentum favours further upside here.
In 2032, RGC is projected to trade between $34.25 and $109.62, averaging $59.68 — a potential gain of +152% from today's $23.71. That is -6% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Regencell Bioscience Holdings Limited's 2033 outlook centres on $67.16, within a $37.09 to $126.68 range. That is up +13% on the projected 2032 average. That marks a +183% change versus current levels. Momentum favours further upside here.
By 2034, RGC could reach as high as $133.82, with a base case around $69.25 and support toward $36.84 — roughly +192% from $23.71. Buyers look set to stay in control over this stretch.
Expect RGC to range from $36.02 to $138.76 through 2035. The $70.22 average target implies a +196% move from current prices. That is up +1% on the projected 2034 average. Momentum favours further upside here.
The RGC price prediction for 2040 points to an average of $122.02 (low $54.91, high $264.36) — a potential gain of +415% on today's $23.71. Buyers look set to stay in control over this stretch.
In 2050, RGC is projected to trade between $136.87 and $699.54, averaging $304.15 — a potential gain of +11.8x from today's $23.71. That is up +149% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in RGC today (≈ 42.176297 RGC) could be worth
$12,827.8
+$11,827.8 (+1183%) by 2050 · US Dollar
Based on the average projected RGC price of $304.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RGCwould be worth at today's price.
$1,000 invested in RGC on May 27, 2025 (≈ 75.754556 RGC) would be worth
$1,796.14
+$796.14 (+79.6%) today · 1.80× · US Dollar
Based on a RGC entry price of $13.2 vs. today's $23.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.39 | $865.64 | -13.4% |
| 1 month ago | $29.2 | $811.99 | -18.8% |
| 3 months ago | $26.29 | $901.86 | -9.8% |
| 6 months ago | $11.53 | $2,056.37 | +105.6% |
| 1 year ago | $13.2 | $1,796.14 | +79.6% |
| All time (4.9y) ago | $0.276316 | $85,807.56 | +8480.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RGC forecast.
Our base-case forecast reaches $47.00 around 2030.
Implied market cap at $47.00: $23.24B
The multi-year forecast shows a clear bullish trajectory after 2026. The 2026 average is $23.71 (ROI 0%, NEUTRAL), while 2027–2050 displays rising averages and strong upside potential, with 2030 average $50.70 and ROI 113.8% (BULLISH).
Notably, the projection reaches $122.02 on average in 2040 with a 414.6% ROI and extends to $304.15 on average in 2050, reflecting an ROI of 1182.8% (BULLISH).
These figures indicate meaningful long-term upside under the forecast, but they are estimates and not guarantees. Currency, market dynamics, and other factors can affect actual outcomes.
Tap a question to reveal the answer.
2030 forecast shows an average of $50.70 with a min of $31.58 and a max of $87.44 and an ROI of 113.8% (sentiment BULLISH).
The forecast depicts a bullish path from 2027 onward with increasing averages and ROIs, including 2030 (ROI 113.8%), 2040 (ROI 414.6%), and 2050 (ROI 1182.8%). These are estimates, not guarantees, and should be weighed with other risks.
Yes—2030 max is $87.44, according to the forecast. The min and avg for 2030 are $31.58 and $50.70 respectively.
The 30-day picture shows a BULLISH sentiment with RSI14 at 40, SMA50 at $27.75, and SMA200 at $21.89. Support is at $23.71 and resistance at $31.47, with a 30-day range of $16.86 to $33.34 and 100% annualized volatility.
Current price: $23.71. Market cap: $11.72B.
Regencell Bioscience Holdings Limited Community Discussion
0Share your Regencell Bioscience Holdings Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.